Whitlow Charles B
Department of Colon and Rectal Surgery, Ochsner Clinic Foundation, New Orleans, LA 70121, USA.
Clin Colon Rectal Surg. 2004 Feb;17(1):21-7. doi: 10.1055/s-2004-823067.
Ulcerative proctitis is an idiopathic mucosal inflammatory disease involving only the rectum and is therefore an anatomically limited form of ulcerative colitis. Diagnosis is made based on clinical presentation, endoscopic appearance, and histopathology. Additionally, other etiologies of proctitis are excluded. The course of the disease is variable ranging from complete resolution to easily maintained remission to frequent relapses or refractory disease. Extension of inflammatory changes involving the proximal colon occurs in some cases. Rectal 5-aminosalicylic acid (5-ASA) or steroids are the initial treatments of choice with oral 5-ASA, sulfasalazine, or steroids used for treatment failures or patients unable to tolerate rectally administered drugs. Immunomodulators like azathioprine and 6-mercaptopurine have been used successfully in small groups of patients who have not responded to 5-ASA or steroids. Oral or rectal 5-ASA products maintain remission but long-term steroid use should be avoided. Rare cases may require surgical therapy.
溃疡性直肠炎是一种仅累及直肠的特发性黏膜炎症性疾病,因此是溃疡性结肠炎在解剖学上的局限形式。诊断基于临床表现、内镜表现和组织病理学检查。此外,还需排除直肠炎的其他病因。疾病进程多变,从完全缓解到易于维持的缓解状态,再到频繁复发或难治性疾病。在某些情况下,炎症变化会累及近端结肠。直肠用5-氨基水杨酸(5-ASA)或类固醇是初始治疗的首选,对于治疗失败或无法耐受直肠给药的患者,则使用口服5-ASA、柳氮磺胺吡啶或类固醇。硫唑嘌呤和6-巯基嘌呤等免疫调节剂已成功用于一小部分对5-ASA或类固醇无反应的患者。口服或直肠用5-ASA产品可维持缓解,但应避免长期使用类固醇。罕见病例可能需要手术治疗。